Add BrightSurf on Google Email

New treatment may cure common hormonal cause of high blood pressure

A new treatment, extended aldosterone synthase inhibition (EASI), has been shown to reverse excess aldosterone production and lower blood pressure in people with primary aldosteronism. The treatment, which involves taking a new class of drugs for 6-12 months, has been found to sustain its benefits for up to two years after treatment en...

SourceQueen Mary University of London·JournalNew England Journal of Medicine·TypeObservational study·DateNov 7, 2026

Burden of chronic kidney disease in China: trends, etiological shifts and key risk factors based on GBD 2023 data

Chronic kidney disease in China has seen rising prevalence, with 156 million people affected in 2023, largely driven by type-2 diabetes and hypertension, with obesity remaining a significant risk factor, and a disparity between men and women in disease burden

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateOct 27, 2026

Could fish consumption reduce the risk of hypertensive disorders of pregnancy?

A new study found that higher fish intake before and during pregnancy was associated with lower odds of certain forms of hypertensive disorders of pregnancy. Women in the highest fish-intake group before pregnancy had 34% lower odds of early-onset HDP.

SourceToyama Regional Center for the Japan Environment and Children's Study, University of Toyama·JournalEuropean Journal of Nutrition·TypeData/statistical analysis·DateOct 23, 2026

Gene editing is coming for common diseases. Are we ready?

Gene therapies can already change clinical care, but their use in common conditions raises concerns about permanent harm and competition with existing treatments. Cardiologists propose strategies for determining when genomic therapy is justified, including considering the benefits, risks, and long-term safety monitoring.

SourceMichigan Medicine - University of Michigan·JournalJAMA Internal Medicine·TypeCommentary/editorial·DateOct 20, 2026

Pregnancy complications linked to higher risk of cardiac and renal health conditions

A UK study found that women with pregnancy complications, including gestational diabetes and high blood pressure, face an elevated risk of developing cardiometabolic-renal conditions in subsequent years. The study, which followed over 1.4 million women, identified associations between postnatal depression and an increased risk of four ...

SourceBMJ Group·JournalBMJ Medicine·TypeObservational study·DateOct 6, 2026

Non-invasive nerve stimulation shows potential for treating uncontrolled high blood pressure

A new non-invasive technique that stimulates nerves through the ear has been shown to be safe and well-tolerated for patients with uncontrolled high blood pressure. The study found that the treatment reduced blood pressure in patients with more severe hypertension, suggesting further investigation is needed to determine its effectiveness.

SourceQueen Mary University of London·JournalHypertension·TypeExperimental study·DateSep 28, 2026

Permissive blood pressure targets in pediatric critical care

A study in pediatric critical care found adopting permissive blood pressure targets resulted in no significant difference in mortality and duration of invasive ventilation at 30 days compared to usual care. The study suggests that a more permissive approach to blood pressure management may be safe for pediatric patients in critical care.

SourceJAMA Network·JournalJAMA·DateSep 28, 2026

Children of centenarians often live longer, develop some age-related diseases later

A study led by Albert Einstein College of Medicine found that children of centenarians live longer and have lower risks of cardiovascular disease and hypertension. The research, analyzing data from three geographically diverse studies, suggests that inherited biological factors beyond lifestyle contribute to exceptional healthy aging.

SourceAlbert Einstein College of Medicine·JournalJAMA Network Open·TypeObservational study·DateAug 26, 2026

The global burden of chronic kidney disease in women and its metabolic–cardiovascular links

The global burden of chronic kidney disease in women has grown, with 359 million cases in 2021, driving increasing mortality rates and disability-adjusted life years. Postmenopausal women and women of reproductive age are particularly vulnerable to metabolic and behavioral drivers that can be modified to reduce risk.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateAug 19, 2026

Taking the stairs could cut risk of early death

A meta-analysis of nearly 1,900 studies found that climbing stairs significantly reduces the risk of dying from cardiovascular disease. Regular stair climbing was associated with lower risks of heart-related problems and major cardiovascular conditions such as heart attack, stroke, and heart failure.

SourceUniversity of East Anglia·JournalAmerican Journal of Cardiovascular Drugs·TypeMeta-analysis·DateAug 12, 2026

Intensive blood pressure-lowering cut recurrent stroke risk by around 38% after brain haemorrhage

A meta-analysis of four randomised controlled trials involving 2,944 adults with intracerebral haemorrhage found that intensive blood pressure-lowering reduced recurrent stroke risk by 38%. The treatment strategy was consistent across all studies, with no observed increase in serious adverse events.

SourceGeorge Institute for Global Health·JournalThe Lancet Neurology·TypeMeta-analysis·DateAug 12, 2026

Chinese Medical Journal review highlights new directions in pulmonary arterial hypertension

A new review highlights how molecular biology advances are reframing PAH as a complex vascular remodeling disease driven by endothelial dysfunction, chronic inflammation, metabolic dysregulation, and genetic susceptibility. Emerging therapies target the BMP/TGF-β pathway, growth factor signaling, and inflammatory pathways.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 11, 2026

Advancing toward non-invasive diagnosis of portal hypertension

Non-invasive approaches are expanding options for assessing portal hypertension, with elastography techniques and biochemical markers showing high sensitivity and specificity. AI-powered predictive models combine clinical data to improve diagnosis, but should not replace invasive HVPG, which remains the gold standard.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalPortal Hypertension & Cirrhosis·TypeLiterature review·DateAug 7, 2026

New approach to obesity classification could better guide treatment decisions

Researchers from Pennington Biomedical Research Center propose a new framework for defining and diagnosing obesity, which considers the effects of excess adiposity on organs and tissues. This approach provides a more biologically grounded and clinically actionable method for guiding treatment decisions.

SourcePennington Biomedical Research Center·JournalJournal of Clinical Endocrinology and Metabolism·DateJul 31, 2026

Heart failure: time for prevention

Heart failure affects over 60 million people worldwide and is a leading cause of hospitalization among older adults. The new expert statement highlights the importance of prevention and early intervention in reducing risk factors such as hypertension, diabetes, and obesity.

SourceWroclaw Medical University·JournalEuropean Heart Journal·TypeLiterature review·DateJul 21, 2026

Untangling the risk factors for developing multiple chronic conditions among UK South Asian populations

A study published in PLOS Medicine found that British Bangladeshi and British Pakistani individuals are more likely to develop multimorbidity, a condition where people experience multiple chronic illnesses simultaneously. The research identified sociodemographic and genetic factors that increase the risk of developing these conditions,...

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateJul 9, 2026

Telehealth navigator program improves blood pressure control among Black patients at federally qualified health centers

A new study shows that a telehealth navigator program can significantly improve blood pressure control among Black patients with hypertension cared for at federally qualified health centers. The program was associated with a 31.4 percentage point increase in the likelihood of having controlled blood pressure.

SourceHarvard Pilgrim Health Care Institute·JournalJournal of General Internal Medicine·DateJun 29, 2026

Women with pre-eclampsia are at increased risk of chronic kidney disease

A new study from Aarhus University reveals that women with pre-eclampsia during pregnancy have a higher risk of developing high blood pressure and chronic kidney disease later in life. High protein levels in the urine during pre-eclampsia are linked to an increased risk of these conditions.

SourceAarhus University·JournalBJOG An International Journal of Obstetrics & Gynaecology·TypeData/statistical analysis·DateJun 18, 2026

Finerenone slows kidney function decline and reduces cardiovascular-kidney risk in non-diabetic chronic kidney disease, major trial shows

The Phase III FIND-CKD trial found that finerenone significantly slowed kidney function decline and reduced the risk of cardiovascular-kidney outcomes in adults with non-diabetic chronic kidney disease. Finerenone also demonstrated a consistent effect across prespecified subgroups, supporting its broad applicability in these patients.

SourceBeyond·JournalNew England Journal of Medicine·DateJun 4, 2026

Early birth safer for mother and baby in high blood pressure pregnancies

A new Cochrane review finds planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth. The practice is found to be safe across both high- and low-income settings, without increasing the likelihood of caesarean section.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateMay 20, 2026

Stretchy implants could stick to arteries to treat high blood pressure

Researchers developed a new class of stretchy bioelectronics that can stick to biological tissue and relieve hypertension while causing less damage to surrounding tissue. The CaroFlex device uses gentle electrical frequencies to modulate the baroreceptor reflex, providing effective treatment for drug-resistant hypertension.

SourcePenn State·JournalDevice·TypeExperimental study·DateMay 15, 2026

Hypertension associated with the risk of extrahepatic cancers in the metabolic dysfunction-associated steatotic liver disease population

A multicenter cross-sectional study found hypertension significantly associated with extrahepatic cancers in the MASLD population. Metabolism-based treatments may have a protective role against extrahepatic cancers in individuals with FIB-4 scores ≥ 1.3.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateMay 12, 2026